You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adrenergic beta-3 Receptor Agonists

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Voiding Disorders, Overactive Bladder Trial (Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin)

Not yet recruiting
  • Voiding Disorders
  • Overactive Bladder
  • Beta3-Agonists, Adrenergic
  • Anticholinergic drug, Solifenacin
  • (no location specified)
Feb 13, 2022

Urgency Urinary Incontinence Trial in United States (Beta3-Agonists, Adrenergic, OnabotulinumtoxinA 100 UNT [Botox])

Not yet recruiting
  • Urgency Urinary Incontinence
  • Beta3-Agonists, Adrenergic
  • OnabotulinumtoxinA 100 UNT [Botox]
  • Birmingham, Alabama
  • +4 more
Mar 28, 2023

Obesity, Prediabetes Trial in La Jolla (Mirabegron)

Not yet recruiting
  • Obesity, Prediabetes
  • La Jolla, California
    UC San Diego Altman Clinical & Translational Research Institute
Nov 21, 2022

Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)

Recruiting
  • Type 2 Diabetes
  • Obesity
  • Formoterol Fumarate 12 micrograms Inhalation Powder
  • +8 more
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Sep 22, 2022

Cardiomyopathy, Dilated, Heart Failure, Autoantibodies Trial in Belgrade, Belgrad (BC 007)

Active, not recruiting
  • Cardiomyopathy, Dilated
  • +2 more
  • BC 007
  • Belgrade, Serbia
  • +2 more
Jul 19, 2022

Asthma Trial in Glendale, London (AZD8630, Placebo)

Recruiting
  • Asthma
  • Tempe, Arizona
  • +14 more
Jan 23, 2023

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Behavioral Intervention
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 5, 2022

Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,

Not yet recruiting
  • Neuroendocrine Neoplasia's (NENs)
  • Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
  • Basel, Switzerland
    Division of Nuclear Medicine, University Hospital Basel
Apr 27, 2022

Hypertrophy, Left Ventricular Trial in Worldwide (drug, procedure, radiation)

Active, not recruiting
  • Hypertrophy, Left Ventricular
  • Brussels, Belgium
  • +8 more
Sep 28, 2021

Prostate Cancer Trial in Bronx (Carvedilol)

Active, not recruiting
  • Prostate Cancer
  • Bronx, New York
    Montefiore Medical Center
Feb 18, 2021

Obesity Trial in Boston (beta3-adrenergic receptor agonist)

Completed
Has Results
  • Obesity
  • beta3-adrenergic receptor agonist
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
May 31, 2019

Delirium, Cognitive Decline, Frailty Trial in Bergen, Oslo, Trondheim (Dexmedetomidine, Clonidine, Natriumchlorid)

Recruiting
  • Delirium
  • +2 more
  • Bergen, Norway
  • +3 more
Apr 25, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 14, 2023

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023

Brown Adipose Tissue Activity in Response to Semaglutide

Not yet recruiting
  • Obesity
  • Semaglutide Injectable Product
  • (no location specified)
Jan 17, 2023

Overactive Bladder, Dementia, Lower Urinary Tract Symptoms Trial in Houston, Temple (Anticholinergic, Beta-3 Agonists,

Unknown status
  • Overactive Bladder
  • +3 more
  • Houston, Texas
  • +1 more
Apr 1, 2020

Advanced Melanoma Trial in New Brunswick (Propranolol, Naltrexone)

Not yet recruiting
  • Advanced Melanoma
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jul 18, 2023

Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic, Ventricular Remodeling Trial in Aurora, Columbus (Ivabradine,

Active, not recruiting
  • Dilated Cardiomyopathies, Idiopathic
  • +3 more
  • Aurora, Colorado
  • +1 more
Oct 31, 2022

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Functional Endoscopic Sinus Surgery, Dexmedetomidine Trial in Tanta (intranasal dexmedetomidine group, intravouns

Recruiting
  • Functional Endoscopic Sinus Surgery
  • Dexmedetomidine
  • intranasal dexmedetomidine group
  • intravouns dexmedetomidine group
  • Tanta, ElGharbiaa, Egypt
    Mohammad Fouad Algyar
Jan 8, 2023

Children With Bronchiolitis

Active, not recruiting
  • Bronchiolitis
    • Hartford, Connecticut
      Connecticut Children's Medical Center
    Jul 8, 2021

    Acute Asthma Responsiveness and B2 Adrenergic Receptors

    Completed
    • Acute Asthma
      • Cleveland, Ohio
        MetroHealth Medical Center
      Aug 26, 2021

      Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder Trial in Palo Alto, San Francisco (Tolterodine Tartrate ER,

      Recruiting
      • Urinary Incontinence, Urge
      • +5 more
      • Tolterodine Tartrate ER
      • +2 more
      • Palo Alto, California
      • +1 more
      Dec 7, 2022

      Overactive Bladder Syndrome, Urge Incontinence Trial in Rogaška Slatina (study group, (sham control))

      Active, not recruiting
      • Overactive Bladder Syndrome
      • Urge Incontinence
      • study group
      • placebo (sham control)
      • Rogaška Slatina, Slovenia
        Damir Franić
      Oct 10, 2023

      Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

      Not yet recruiting
      • ITP - Immune Thrombocytopenia
      • eltrombopag and romiplastim
      • (no location specified)
      Nov 16, 2023